Fil LTD Baxter International Inc Transaction History

Fil LTD

$103 Billion
Q3 2024

A detailed history of Fil LTD transactions in Baxter International Inc stock. As of the latest transaction made, Fil LTD holds 681,710 shares of BAX stock, worth $20.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

681,710

Previous 1,789,212 61.9%

Holding current value

$20.1 Million

Previous $59.8 Million 56.75%

% of portfolio

0.03%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$32.85 - $40.26 $36.4 Million - $44.6 Million	-1,107,502 Reduced 61.9%	681,710 $25.9 Million
Q2 2024 Aug 13, 2024	SELL	$32.87 - $43.55 $21.9 Million - $29 Million	-666,308 Reduced 27.14%	1,789,212 $59.8 Million
Q1 2024 May 13, 2024	SELL	$37.88 - $43.77 $10.9 Million - $12.6 Million	-286,824 Reduced 10.46%	2,455,520 $105 Million
Q4 2023 Feb 13, 2024	BUY	$31.71 - $38.95 $14.2 Million - $17.4 Million	447,518 Added 19.5%	2,742,344 $106 Million
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $58 Million - $76.6 Million	-1,553,553 Reduced 40.37%	2,294,826 $86.6 Million
Q2 2023 Aug 11, 2023	SELL	$39.98 - $47.68 $12.1 Million - $14.4 Million	-301,714 Reduced 7.27%	3,848,379 $175 Million
Q1 2023 May 11, 2023	BUY	$37.58 - $52.57 $110 Million - $154 Million	2,935,716 Added 241.75%	4,150,093 $168 Million
Q4 2022 Feb 13, 2023	SELL	$49.7 - $57.71 $2.23 Million - $2.59 Million	-44,859 Reduced 3.56%	1,214,377 $61.9 Million
Q3 2022 Nov 10, 2022	SELL	$53.86 - $66.8 $41.5 Million - $51.5 Million	-771,071 Reduced 37.98%	1,259,236 $67.8 Million
Q2 2022 Aug 12, 2022	BUY	$63.83 - $80.0 $3.77 Million - $4.72 Million	59,056 Added 3.0%	2,030,307 $130 Million
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $18.4 Million - $21.5 Million	240,029 Added 13.86%	1,971,251 $153 Million
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $23 Million - $26.9 Million	308,624 Added 21.69%	1,731,222 $149 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $1.9 Million - $2.15 Million	25,706 Added 1.84%	1,422,598 $114 Million
Q2 2021 Aug 13, 2021	SELL	$80.5 - $88.01 $17.3 Million - $18.9 Million	-215,170 Reduced 13.35%	1,396,892 $112 Million
Q1 2021 May 14, 2021	SELL	$76.38 - $86.03 $123 Million - $138 Million	-1,607,822 Reduced 49.93%	1,612,062 $136 Million
Q4 2020 Feb 08, 2021	BUY	$75.39 - $82.36 $114 Million - $125 Million	1,512,248 Added 88.56%	3,219,884 $258 Million
Q3 2020 Nov 13, 2020	BUY	$78.33 - $90.73 $8.07 Million - $9.34 Million	102,982 Added 6.42%	1,707,636 $137 Million
Q2 2020 Aug 13, 2020	SELL	$78.66 - $94.14 $51.9 Million - $62.1 Million	-659,507 Reduced 29.13%	1,604,654 $138 Million
Q1 2020 May 14, 2020	BUY	$71.57 - $93.3 $16.5 Million - $21.5 Million	230,701 Added 11.35%	2,264,161 $184 Million
Q4 2019 Feb 07, 2020	BUY	$76.7 - $88.45 $24.5 Million - $28.3 Million	319,891 Added 18.67%	2,033,460 $170 Million
Q3 2019 Nov 13, 2019	BUY	$81.4 - $89.78 $2.68 Million - $2.95 Million	32,897 Added 1.96%	1,713,569 $150 Million
Q2 2019 Aug 13, 2019	SELL	$73.44 - $82.41 $27.6 Million - $31 Million	-376,256 Reduced 18.29%	1,680,672 $138 Million
Q1 2019 May 13, 2019	BUY	$64.48 - $81.31 $52 Million - $65.6 Million	806,368 Added 64.48%	2,056,928 $167 Million
Q4 2018 Feb 13, 2019	BUY	$61.45 - $77.8 $35.2 Million - $44.5 Million	572,546 Added 84.44%	1,250,560 $82.3 Million
Q3 2018 Nov 09, 2018	BUY	$70.71 - $77.75 $1,838 - $2,021	26 Added 0.0%	678,014 $52.3 Million
Q2 2018 Aug 10, 2018	BUY	$63.43 - $75.41 $43 Million - $51.1 Million	677,988 New	677,988 $50.1 Million
Q3 2017 Nov 13, 2017	SELL	$59.5 - $64.61 $8.12 Million - $8.82 Million	-136,487 Closed	0 $0
Q2 2017 Aug 29, 2017	BUY	N/A	136,487	136,487 $8.26 Million

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account